DRD2 and amyotrophic lateral sclerosis: Also, DRD2 agonist, bromocriptine methylate, can suppress glial inflammation, thus mitigating disease progression in a mouse model of ALS (Tanaka et al., 2011), and quinpirole‐mediated regulation of DRD2 can inhibit glial neuroinflammation both in the cortex and in the Str after TBI (Alam et al., 2021).